Animal Parasiticides Market Size & Growth Forecast 2027–2036, By Segments (Type, Animal Type, Product, End Use, Drug Class), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Animal Parasiticides Market size stood at USD 14.09 billion in 2026 and is predicted to grow at a 5.62% CAGR from 2027 to 2036, exceeding USD 24.34 billion by 2036. The industry revenue for 2027 is calculated at USD 14.76 billion.
Get more details on this report
Request Free Sample ReportAnimal Parasiticides Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 40.18% of the market in 2026, supported by high pet ownership, established veterinary infrastructure, preventive healthcare practices, and livestock parasite-control requirements.
- Asia Pacific is the fastest-growing region, driven by expanding livestock and poultry production, rising pet ownership, improving veterinary access, and greater awareness of preventive animal healthcare.
Segment Momentum
- Prescription products held the largest share at 71.14% in 2026, reflecting the importance of veterinary oversight, targeted treatment selection, dosage management, and monitoring for complex parasitic infections.
- Over-the-counter products are expected to grow fastest as pet owners and livestock handlers seek convenient access to routine parasite prevention and treatment through retail and online channels.
Market Expansion Drivers
- Increasing livestock population and pet ownership.
- Rising prevalence of parasitic infections in animals.
- Expansion of veterinary healthcare infrastructure in emerging markets.
Leading Market Participants
- Leading players in the animal parasiticides market include Zoetis (USA), Elanco Animal Health (USA), Merck Animal Health (USA), Boehringer Ingelheim Animal Health (Germany), Ceva Santé Animale (France), Virbac (France), Vetoquinol (France), Dechra Pharmaceuticals (UK), Phibro Animal Health (USA), Huvepharma (Bulgaria).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 14.09 billion
- 2027 Estimated Market Size: USD 14.76 billion
- Projected Market Size: USD 24.34 billion by 2036
- Growth Forecast: 5.62% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Type (Prescription) | Animal Type (Companion Animals) | Product (Ectoparasiticides) | End Use (Animal Farms) | Drug Class (Macrocyclic Lactones)
- Emerging Opportunity Segment: Type (Over the Counter (OTC)) | Animal Type (Companion Animals) | Product (Ectoparasiticides) | End Use (Animal Farms) | Drug Class (Macrocyclic Lactones)
Market Growth Drivers and Industry Trends
Increasing livestock population and pet ownership
The expansion of livestock farming and increasing pet ownership are contributing to sustained demand for animal parasiticides used to prevent and control parasitic infestations. Growing livestock production requires effective parasite management to maintain animal health, productivity, and farm efficiency, while the increasing number of companion animals is encouraging greater attention to routine preventive healthcare. Rising awareness among livestock producers and pet owners regarding parasite prevention is further supporting the regular use of veterinary parasiticides across different animal categories.
Rising prevalence of parasitic infections in animals
The continued occurrence of internal and external parasitic infections is driving demand for effective parasiticides across livestock and companion animal healthcare. Parasites can adversely affect animal health, growth, nutrition, and productivity, creating a need for preventive and therapeutic treatment approaches. Increasing awareness of parasite-related health risks, changing environmental conditions, and the need for routine animal health management are encouraging greater adoption of products designed to control worms, ticks, mites, fleas, and other common parasites.
Expansion of veterinary healthcare infrastructure in emerging markets
The development of veterinary healthcare infrastructure in emerging markets is improving access to animal health services, diagnostics, preventive treatments, and parasite management programs. Expanding veterinary clinics, livestock health services, animal pharmacies, and professional care networks are making parasiticides more accessible to farmers and pet owners. Growing awareness of preventive veterinary care and increasing integration of animal health services into livestock management practices are further supporting the adoption of parasiticides across developing animal healthcare markets.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing livestock population and pet ownership | 2.1% | Medium term (2–5 yrs) | Asia Pacific; North America; Europe | Low | Moderate |
| Rising prevalence of parasitic infections in animals | 1.5% | Short term (≤ 2 yrs) | Asia Pacific; North America; Europe | Medium | Fast |
| Expansion of veterinary healthcare infrastructure in emerging markets | 1% | Long term (5+ yrs) | Asia Pacific; Latin America; MEA | Low | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held a 40.18% share in 2026, led by high pet ownership, strong veterinary healthcare infrastructure, and increasing awareness of parasite prevention and animal health management. Animal parasiticides are widely used to prevent and control parasites that can affect the health and productivity of companion animals and livestock. Growing awareness among pet owners regarding routine preventive care is encouraging regular use of products designed to control fleas, ticks, worms, and other parasites. The region's established veterinary clinics, animal healthcare services, and distribution networks are also facilitating access to parasite prevention and treatment products. In the livestock sector, maintaining animal health and preventing parasitic infections are important for supporting productivity and reducing disease-related losses. Increasing expenditure on companion animal healthcare and growing emphasis on preventive veterinary care are further supporting market demand across North America.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to grow at the fastest rate, influenced by expanding livestock production, rising companion animal ownership, and improving access to veterinary healthcare services. The region's growing livestock and poultry industries are increasing the need for effective parasite control to maintain animal health, productivity, and farm efficiency. At the same time, urbanization and changing lifestyles are contributing to rising pet ownership, creating additional demand for preventive animal healthcare products. Improving veterinary infrastructure and increasing awareness of animal diseases are encouraging farmers and pet owners to adopt more consistent parasite prevention practices. In addition, growing investments in animal healthcare services and expanding access to veterinary products are supporting market development across emerging economies. The increasing focus on preventive animal health and improved livestock management is expected to further strengthen demand for animal parasiticides throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Broad Veterinary CoverageThe U.S. animal parasiticides market spans companion animals and livestock, creating demand for convenient, effective parasite-control products across different treatment settings. Commercial priorities include product accessibility, administration convenience, and solutions addressing routine parasite management in both veterinary and animal-care channels.
Germany 🇩🇪
Preventive Animal CareGermany’s animal parasiticides market emphasizes structured veterinary care and routine parasite prevention across companion animals and livestock. Suppliers are prioritizing convenient treatment formats, responsible use, and products that fit professional veterinary protocols and increasingly attentive animal-health management practices.
Japan 🇯🇵
Companion Animal CareJapan’s animal parasiticides market is closely linked to organized companion-animal healthcare, where ease of administration and regular preventive treatment influence purchasing decisions. Companies are focusing on user-friendly formulations, veterinary-channel adoption, and dependable parasite-control solutions suited to routine pet care.
South Korea 🇰🇷
Pet Health ExpansionSouth Korea’s animal parasiticides market is increasingly shaped by structured companion-animal healthcare and demand for convenient preventive treatments. Market priorities include easy-to-administer formulations, veterinary distribution, and products that support regular parasite management as pet owners place greater emphasis on routine animal health.
France 🇫🇷
Veterinary Prevention FocusFrance’s animal parasiticides market is centered on preventive veterinary care across companion animals and livestock, with treatment convenience influencing product selection. Suppliers are emphasizing practical administration formats, responsible parasite management, and solutions that integrate effectively into routine veterinary and animal-care practices.
Italy 🇮🇹
Companion-Livestock BalanceItaly’s animal parasiticides market serves both companion-animal care and livestock health requirements, creating demand for adaptable parasite-control solutions. Commercial priorities include convenient dosing, veterinary-channel availability, and products capable of addressing recurring parasite-management needs across diverse animal-care settings.
Animal Parasiticides Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Prescription (Largest Segment) vs Over the Counter (OTC) (Fastest-Growing Segment)
The prescription segment accounted for the largest share of the animal parasiticides market in 2026, at 71.14% share, reflecting the role of veterinary oversight in treating and preventing parasitic infections that require specific diagnosis, dosage, or monitoring. Prescription products are often selected for animals with complex health needs or persistent infestations, as veterinarians can recommend treatments based on species, weight, medical history, and parasite type. Their use is also supported by established clinical guidance and the availability of targeted formulations for a range of internal and external parasites. Meanwhile, the over-the-counter segment is expected to grow at the fastest pace as pet owners and livestock handlers increasingly seek accessible solutions for routine parasite prevention and treatment. OTC products offer convenience through direct retail and online availability, enabling consumers to address common parasitic concerns without a veterinary prescription. Growing awareness of preventive animal healthcare, along with demand for easy-to-use topical and oral treatments, is supporting adoption of this segment.
Animal Type Segment Analysis: Companion Animals (Largest & Fastest-Growing Segment)
Companion animals accounted for the largest share of the animal parasiticides market in 2026, at 58.61% share, and are also expected to remain the fastest-growing animal type segment. Increasing pet ownership and the growing emphasis on preventive veterinary care are driving demand for products that protect dogs, cats, and other household animals against fleas, ticks, mites, and internal parasites. Pet owners are becoming more attentive to parasite control because infestations can affect animal comfort and health, while some parasites may also pose risks to humans. Regular veterinary checkups, greater awareness of year-round prevention, and the availability of convenient treatment formats are further supporting product use. In addition, the humanization of pets is encouraging owners to invest in routine healthcare and premium veterinary products, strengthening demand for companion-animal parasiticides.
Product Segment Analysis: Ectoparasiticides (Largest & Fastest-Growing Segment)
Ectoparasiticides represent the largest product segment in the animal parasiticides market in 2026 and are also expected to record the fastest growth. These products address external parasites such as fleas, ticks, mites, and lice, which can cause irritation, skin conditions, and other health complications in animals. Their broad relevance across companion animals and livestock supports demand from both pet owners and animal healthcare professionals. The need for consistent external parasite control is reinforced by concerns around recurring infestations, animal welfare, and the potential transmission of vector-borne diseases. Product innovation in topical applications, collars, sprays, and oral treatments is also improving convenience and supporting wider use. As awareness of preventive parasite management increases, ectoparasiticides are positioned to retain a central role in animal healthcare routines.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Over the Counter (OTC), Prescription | Prescription | Over the Counter (OTC) |
| Animal Type | Companion Animals, Farm Animals | Companion Animals | Companion Animals |
| Product | Ectoparasiticides, Endoparasiticides, Endectocides | Ectoparasiticides | Ectoparasiticides |
| End Use | Veterinary Hospitals and Clinics, Animal Farms, Home Care Settings | Animal Farms | Animal Farms |
| Drug Class | Chemical Synthetic, Macrocyclic Lactones, Pyrethroids, Organophosphates, Benzimidazoles, Others | Macrocyclic Lactones | Macrocyclic Lactones |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Animal parasiticide manufacturers face diverging market drivers across companion pet and livestock sectors, yet both segments center heavily on broad-spectrum efficacy and administration convenience. Pet owners increasingly favor easy-to-administer oral chewables or monthly topicals that enhance treatment compliance, whereas livestock producers evaluate parasiticide programs through herd productivity gains, cost-per-dose economics, and strict food-safety withdrawal timelines. Underpinning the entire competitive landscape is the growing operational risk of parasitic resistance. As efficacy drops from repeated chemical exposure, pharmaceutical developers must differentiate through new active ingredient rotation programs, stewardship support, and combined broad-spectrum formulations that protect long-term therapeutic value while safeguarding animal health across regional parasite variations.
Key companies in the animal parasiticides market:
- Zoetis (USA)
- Elanco Animal Health (USA)
- Merck Animal Health (USA)
- Boehringer Ingelheim Animal Health (Germany)
- Ceva Santé Animale (France)
- Virbac (France)
- Vetoquinol (France)
- Dechra Pharmaceuticals (UK)
- Phibro Animal Health (USA)
- Huvepharma (Bulgaria)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis (USA) | |||||||
| Elanco Animal Health (USA) | |||||||
| Merck Animal Health (USA) | |||||||
| Boehringer Ingelheim Animal Health (Germany) | |||||||
| Ceva Santé Animale (France) | |||||||
| Virbac (France) | |||||||
| Vetoquinol (France) | |||||||
| Dechra Pharmaceuticals (UK) | |||||||
| Phibro Animal Health (USA) | |||||||
| Huvepharma (Bulgaria) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Merck & Co., Inc. | July 2025 | Secured U.S. FDA approval for BRAVECTO QUANTUM, an extended-release injectable suspension designed to deliver once-annual treatment and protection against flea and tick infestations in dogs. |
| Zoetis Services LLC | April 2025 | Received U.S. FDA approval for an expanded indication of Simparica Trio, a broad-spectrum combination canine parasiticide, adding prevention of flea-transmitted tapeworm infections to its label. |
| Phibro Animal Health Corporation | April 2024 | Signed a definitive agreement to acquire the medicated feed additive portfolio and related water-soluble products from Zoetis Services LLC for USD 350 million, expanding its parasite control and livestock health offerings. |
| Norbrook | June 2023 | Launched Tauramox (moxidectin) 1% injectable solution in the U.S., a ready-to-use parasiticide targeting gastrointestinal roundworms, lungworms, cattle grubs, mites, and lice in beef and non-lactating dairy cattle. |
| Merck Animal Health | May 2023 | Received authorization from the Australian Pesticides and Veterinary Medicines Authority (APVMA) for a unique 12-month injectable formulation of BRAVECTO (fluralaner) to treat and prevent flea infestations in dogs. |
| Merck Animal Health | January 2023 | Obtained U.S. FDA approval for an expanded indication of BRAVECTO chews for dogs to treat and manage Asian longhorned ticks, an invasive Ixodid species prevalent in the United States. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Animal Parasiticides Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Route of Administration | Oral, Topical, Injectable, Pour-on/Drench |
| Parasite Indication | Fleas & Ticks, Mites & Lice, Gastrointestinal Worms, Heartworms, Other Parasites |
| Duration of Protection | Short-term Protection, Monthly Protection, Multi-month Protection, Long-term Protection |
Animal Parasiticides Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Companion Animal Preventive Care Trends |
|
| Resistance Management Landscape |
|
| Emerging Parasite Threat Analysis |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How big is the animal parasiticides market?
What is the expected industry size of animal parasiticides by 2036?
How is expanding animal healthcare infrastructure supporting parasiticide adoption in emerging markets?
How are livestock expansion and rising pet ownership shaping demand for animal parasiticides?
Which type segment dominated the animal parasiticides market in 2026?
Which type segment is expected to grow fastest in the animal parasiticides market?
Why does North America lead the animal parasiticides market?
What is driving animal parasiticides market growth in Asia Pacific?
Which companies are driving growth in the animal parasiticides landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook